Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

5.41
-0.3200-5.58%
Post-market: 5.450.0399+0.74%18:18 EDT
Volume:2.75M
Turnover:15.14M
Market Cap:614.05M
PE:-1.98
High:5.87
Open:5.71
Low:5.38
Close:5.73
52wk High:8.90
52wk Low:2.25
Shares:113.50M
Float Shares:58.41M
Volume Ratio:1.15
T/O Rate:4.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7367
EPS(LYR):-2.2987
ROE:-205.81%
ROA:-38.43%
PB:16.33
PE(LYR):-2.35

Loading ...

Compass Pathways PLC reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 04, 2025

Compass Pathways Unveils Investor Presentation Highlighting Progress in Psilocybin Therapy for Depression and PTSD

Reuters
·
Nov 04, 2025

BUZZ-Compass Pathways jumps as it speeds up launch plans for depression drug

Reuters
·
Nov 04, 2025

Biotech firm Compass Pathways' operating income beats Q3 analyst expectations

Reuters
·
Nov 04, 2025

Stock Track | COMPASS Pathways Soars 11.60% Pre-market on Accelerated Commercialization Plans for COMP360

Stock Track
·
Nov 04, 2025

Compass Pathways Q3 EPS $(1.44) Misses $(0.38) Estimate

Benzinga
·
Nov 04, 2025

BRIEF-COMPASS Pathways Q3 EPS USD -1.44

Reuters
·
Nov 04, 2025

Compass Pathways reports Q3 2025 results with cash position of $185.9 million

Reuters
·
Nov 04, 2025

Compass Pathways: Accelerating Commercialization Readiness Plans for Comp360 by 9-12 Months

THOMSON REUTERS
·
Nov 04, 2025

Compass Pathways: Disclosure of 26-Week (Part B) Comp006 Data Expected in Early Q3 2026

THOMSON REUTERS
·
Nov 04, 2025

Compass Pathways Q3 Pretax Profit USD -137.947 Million

THOMSON REUTERS
·
Nov 04, 2025

Press Release: Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months

Dow Jones
·
Nov 04, 2025

Compass Pathways Files Initial Statement of Beneficial Ownership for Director Jeffrey M. Jonas

Reuters
·
Nov 01, 2025

Compass Pathways PLC expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
Oct 31, 2025

Compass Pathways, NeuroKaire enter R&D collaboration

TIPRANKS
·
Oct 30, 2025

Neurokaire Enters Into R&D Collaboration With Compass Pathways to Pioneer Precision Treatments for Depression

THOMSON REUTERS
·
Oct 30, 2025

Compass Pathways Appoints Dr. Jeffrey Jonas to Board

Reuters
·
Oct 29, 2025

Compass Pathways Appoints DR. Jeffrey Jonas to Board of Directors

THOMSON REUTERS
·
Oct 29, 2025

Compass Pathways plc to Release Third Quarter 2025 Financial Results

Reuters
·
Oct 28, 2025

Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025

THOMSON REUTERS
·
Oct 28, 2025